Pyrazolopyrimidines as highly potent and selective, ATP-competitive inhibitors of the mammalian target of rapamycin (mTOR): Optimization of the 1-substituent

Kevin J. Curran, Jeroen C. Verheijen, Joshua A. Kaplan, David J. Richard, Lourdes Toral‐Barza, Irwin Hollander, Judy Lucas, Semiramis Ayral‐Kaloustian, Ker Yu, Arie Zask

Bioorganic & Medicinal Chemistry Letters · 2010 · 63 citations · 14 references

DOIFull text

Open access

Concepts

References

14